In autoantibody-driven rheumatoid arthritis, TH17 cells regulated the expression of β-galactoside α2,6-sialyltransferase 1 through IL-22 and IL-21, which induced glycan changes in autoantibodies coinciding with the inflammatory phase of arthritis (18). Here, IL22 is linked to arthritic joint disease.